Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy delivers semaglutide—a GLP-1 receptor agonist—via weekly injection, and clinical trials show patients lose an average of 15% of body weight over 68 weeks with consistent use. The medication works by slowing gastric emptying, reducing appetite signals in the brain, and improving blood sugar control. PlexusDx provides access to compounded semaglutide injection with identical pharmacology but greater affordability and flexibility.

How Wegovy Weekly Injections Work in Your Body

Wegovy's active ingredient, semaglutide, mimics glucagon-like peptide-1 (GLP-1), a natural hormone that regulates hunger and blood sugar. When injected once per week under the skin, semaglutide travels through your bloodstream and activates GLP-1 receptors in your hypothalamus—the brain's appetite control center. This activation triggers three major responses: decreased hunger signals, slower stomach emptying so you feel full longer, and improved insulin secretion to stabilize energy levels.

The medication reaches peak blood levels approximately 1 to 3 days after injection, then gradually declines over the remaining six days until your next dose. This sustained-release profile means you experience appetite suppression throughout the entire week without daily pills or multiple injections. Because semaglutide has a long half-life of about seven days, missing one dose rarely causes immediate side effects, though consistent weekly scheduling maximizes effectiveness.

Wegovy Dosing Schedule: Starting Low and Going Higher

Wegovy follows a 16-week dose escalation protocol designed to minimize nausea and other gastrointestinal side effects. Patients begin with a 0.25 mg injection once weekly for four weeks, then increase to 0.5 mg weekly for the next four weeks. At week nine, the dose jumps to 0.75 mg, and at week 13, patients reach the standard maintenance dose of 1.0 mg once per week. Some individuals tolerate acceleration to 1.7 mg or 2.4 mg weekly if weight loss plateaus, though 1.0 mg remains the most common long-term dose.

This gradual titration strategy gives your gastrointestinal tract time to adapt to semaglutide's effects on stomach emptying and hunger signaling. Starting too high causes nausea, vomiting, and diarrhea that discourage treatment adherence, whereas slow escalation allows most patients to reach their target dose comfortably. Individual tolerance varies: some people feel ready to increase after two weeks, while others need a full month at each step. PlexusDx compounded semaglutide injection offers the same flexibility to adjust timing based on your personal tolerance and response.

Clinical Evidence: Weight Loss and Health Outcomes with Weekly Semaglutide

The landmark STEP trials, which established Wegovy's effectiveness, enrolled over 4,500 participants with obesity or overweight with weight-related conditions. Participants receiving semaglutide 1.0 mg once weekly lost an average of 10.6 kg (23 lbs) over 68 weeks, while those on the highest dose of 2.4 mg lost 17.4 kg (38 lbs) compared to placebo. Beyond weight loss, patients experienced improvements in blood pressure, fasting glucose, and cardiovascular markers, demonstrating semaglutide's broader metabolic benefits.

Safety data from these trials showed that nausea occurred in approximately 25% of patients, but severity typically peaked during dose escalation and diminished with continued use. Gastrointestinal side effects like diarrhea and constipation affected 20-25% of participants, though most described these as mild to moderate rather than severe. Serious adverse events occurred rarely, and long-term follow-up data spanning multiple years shows sustained weight loss and improved metabolic health markers in people who maintain consistent weekly injections.

PlexusDx Compounded Semaglutide vs. Wegovy: What You Need to Know

PlexusDx compounded semaglutide injection contains the identical active pharmaceutical ingredient as brand-name Wegovy and works through the same biological mechanism. The compound is manufactured in licensed 503A compounding pharmacies that follow strict quality and sterility standards verified by state pharmacy boards and the U.S. Pharmacopeia. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization, making it accessible to anyone seeking GLP-1 therapy regardless of coverage status.

Pricing represents the most significant advantage: PlexusDx semaglutide injection starts at $189/mo (or $149/mo on the 6-month plan), compared to Wegovy's typical out-of-pocket cost of $500-$1,400 monthly depending on insurance coverage. Your dose may need to go up as you progress through the titration protocol or if your weight loss plateaus—your price won't. PlexusDx also accepts HSA and FSA funds, further reducing your net cost. If you have specific genetic variations affecting peptide sensitivity or GLP-1 receptor function, the optional Precision Peptide Genetic Test ($99 add-on after your first month) can reveal your personalized pathway for optimal dosing and efficacy.

Managing Side Effects and Optimizing Your Weekly Injection Routine

Nausea during the first two weeks of semaglutide injection typically improves by eating smaller, low-fat meals and avoiding high-sugar or high-fat foods that slow stomach emptying further. Staying hydrated, taking injections on the same day and time each week, and keeping an injection log help your body establish a predictable rhythm. If nausea persists beyond the first month at your current dose, delaying dose escalation for an additional two weeks allows your gastrointestinal system more adaptation time without sacrificing long-term results.

Injection site reactions like mild redness or bruising are normal and usually fade within hours to days. Rotating your injection sites—alternating between your abdomen, thighs, and upper arms—prevents lipohypertrophy (fatty tissue buildup) and ensures consistent drug absorption. If you experience severe allergic reactions, signs of pancreatitis (severe abdominal pain), or persistent vomiting, contact your healthcare provider immediately, though such complications remain rare in real-world use.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Wegovy really a once-weekly injection, or do I need multiple doses per week?

Wegovy is administered as a single subcutaneous injection once per week on the same day and time. After injecting, semaglutide circulates in your bloodstream for approximately seven days, providing continuous appetite suppression throughout the week. You do not need additional injections or oral doses between weekly injections.

How long does it take to reach the full therapeutic dose with Wegovy?

The standard Wegovy titration protocol spans 16 weeks, starting at 0.25 mg and increasing every four weeks until reaching the maintenance dose of 1.0 mg weekly. Some individuals progress faster or slower depending on tolerance, and doses up to 2.4 mg may be used if needed. PlexusDx compounded semaglutide follows the same evidence-based escalation approach, giving you flexibility to match your personal tolerance.

What does a Wegovy injection actually cost compared to PlexusDx semaglutide?

Brand-name Wegovy typically costs $500-$1,400 per month out-of-pocket after insurance, with some patients paying less if they qualify for manufacturer discounts. PlexusDx compounded semaglutide injection starts at $189/mo (or $149/mo on the 6-month plan) flat, and your price remains the same whether you stay at 0.25 mg or advance to 2.4 mg—your dose may go up, your price won't. PlexusDx also accepts HSA and FSA funds, further reducing your net expense.

Are compounded semaglutide injections as safe and effective as brand-name Wegovy?

PlexusDx compounded semaglutide contains the same active ingredient manufactured in licensed 503A compounding pharmacies meeting rigorous sterility and quality standards. Clinical studies demonstrate semaglutide's safety and efficacy regardless of manufacturer, with average weight loss of 10-17% over 68 weeks. Your healthcare provider should monitor your progress with regular check-ins, just as with any GLP-1 therapy.

Can genetic testing help me optimize my semaglutide dose and results?

PlexusDx Precision Peptide Genetic Test analyzes key variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), and appetite-control genes like MC4R and FTO that influence your response to GLP-1 therapy. Understanding your genetic predisposition helps your provider personalize your titration pace and target dose for maximum weight loss and tolerability. The test costs $99 as an add-on after your first month of treatment.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves